Stay updated on Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 and removed prior notices (including a funding lapse notice and Revision: v3.4.1). These are administrative site updates and do not affect the study content.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice about a lapse in government funding and NIH operations was added, and the page now shows Revision: v3.4.1 in place of v3.4.0. These changes do not affect the study content, eligibility criteria, outcomes, or how users interact with the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdditions include a glossary toggle and updated metadata fields (Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0), while deletions remove Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4. These are administrative UI/metadata updates and do not affect the study content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedMinor site revision from v3.3.3 to v3.3.4 with no changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded an Ohio location for the study and updated the 'Last Update Posted' field to 'Estimated'; revision v3.3.3 is now shown.SummaryDifference0.7%

- Check92 days agoChange DetectedMinor wording updates were made to the Publications section and to the revision notes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Temozolomide in Small-Cell Lung Cancer Clinical Trial page.